Drug-Eluting Stents
Showing 1 - 25 of >10,000
Coronary Heart Disease, Angioplasty, Balloon Trial in Xi'an (Drug-coated balloon, Drug-eluting stents)
Active, not recruiting
- Coronary Heart Disease
- Angioplasty, Balloon
- Drug-coated balloon
- Drug-eluting stents
-
Xi'an, Shannxi, ChinaLing Tao
Jun 29, 2023
Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)
Recruiting
- Drug-eluting Stent
- Coronary Artery Disease
- Genoss® DES system, Genoss® Osfit system
-
Suwon, Korea, Republic ofAjou University Hospital
Sep 27, 2023
Intracranial Arteriosclerosis, Stenosis Artery, Drug-Eluting Stents Trial (Drug-Eluting Stents)
Not yet recruiting
- Intracranial Arteriosclerosis
- +3 more
- Drug-Eluting Stents
- (no location specified)
Jan 11, 2023
Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul
Not yet recruiting
- Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
- ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
- high-intensity statin monotherapy (atoravastatin 40mg)
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 21, 2023
First, Second, and New Drug-Eluting Stents in Routine Clinical
Recruiting
- Coronary Artery Disease
- Percutaneous Transluminal Coronary Angioplasty
-
Multiple Locations, Korea, Republic ofKorean centres
Jul 14, 2022
Coronary Artery Disease Trial in Jining (SeQuent® Please drug coating balloon(DCB),Firehawk family drug eluting stent(DES))
Recruiting
- Coronary Artery Disease
- SeQuent® Please drug coating balloon(DCB),Firehawk family drug eluting stent(DES)
-
Jining, Shandong, ChinaJining Medical University Affiliated Hospital
Jul 23, 2023
Coronary Artery Disease Trial in Seoul
Recruiting
- Coronary Artery Disease
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 14, 2022
Coronary Artery Disease Trial in Seoul (Type of stent, Duration of DAPT)
Recruiting
- Coronary Artery Disease
- Type of stent
- Duration of DAPT
-
Seoul, Korea, Republic ofSamsung Medical Center
May 8, 2022
Washington Hospital Center With Drug Eluting Stents - Synergy
Active, not recruiting
- Incidence of Major Adverse Cardiac Events
- PCI with Synergy Stent
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Jan 3, 2022
Coronary Artery Disease, Drug-eluting Stents Trial in Yongin (ultimaster)
Recruiting
- Coronary Artery Disease
- Drug-eluting Stents
- ultimaster
-
Yongin, Gyeonggi-do, Korea, Republic ofYongin Severance Hospital
Dec 22, 2022
Coronary Artery Endothelial Dysfunction With Drug Coated
Suspended
- Coronary Artery Disease
- +2 more
-
Norwich, Norfolk, United KingdomNorfolk & Norwich University Hospital
May 9, 2022
Coronary Artery Disease Trial in Taoyuan (Orsiro stent, Xience stent, Any drug-eluting stent)
Not yet recruiting
- Coronary Artery Disease
- Orsiro stent
- +2 more
-
Taoyuan, TaiwanLinkou Chang Gung Memorial Hospital
Jan 16, 2022
Popliteal Arterial Stenosis Trial in L'Hospitalet De Llobregat (Pharmacoactive balloon angioplasty. Lutonix®, Mimetic
Recruiting
- Popliteal Arterial Stenosis
- Pharmacoactive balloon angioplasty. Lutonix®
- Mimetic stent.Supera®
-
L'Hospitalet De Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Dec 13, 2022
Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents Trial in Beijing, Xuzhou, Chengdu (CYP2C19 genotype testing)
Recruiting
- Angina, Stable
- +3 more
- CYP2C19 genotype testing
-
Beijing, Beijing, China
- +11 more
Nov 4, 2021
Coronary Artery Disease Trial in Seoul (Aspirin, Clopidogrel)
Recruiting
- Coronary Artery Disease
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 8, 2022
Atrial Fibrillation Trial in Seoul (NOAC monotherapy, Dual therapy with apixaban and clopidogrel)
Recruiting
- Atrial Fibrillation
- NOAC monotherapy
- Dual therapy with apixaban and clopidogrel
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital, Yonsei University Health Syst
Sep 10, 2021
Coronary Artery Disease, Chronic Coronary Syndrome, Drug Eluting Stents Trial in Alexandria (Percutaneous Coronary Intervention
Recruiting
- Coronary Artery Disease
- +2 more
- Percutaneous Coronary Intervention and Stent Implantation
-
Alexandria, Egypt
- +1 more
Jul 2, 2021
Chronic Kidney Diseases Trial in Seoul (dual anti-platelet therapy at least 6 months, dual anti-platelet therapy 3months or
Recruiting
- Chronic Kidney Diseases
- dual anti-platelet therapy at least 6 months
- dual anti-platelet therapy 3months or less
-
Seoul, Korea, Republic ofDivision of Cardiology, Yonsei Cardiovascular Hospital, Yonsei U
Jul 28, 2021
Coronary Artery Disease Trial in Belgium, New Zealand (Percutaneous Coronary Intervention with drug eluting stents)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention with drug eluting stents
-
Antwerp, Belgium
- +7 more
Mar 11, 2022
High Bleeding Risk, Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI) Trial in Ciudad de México (Drug
Terminated
- High Bleeding Risk
- +2 more
- Drug Eluting Balloon (DEB)
- Drug Eluting Stents (DES)
-
Ciudad de México, MexicoInstituto Nacional de Cardiologia "Ignacio Chávez"
Oct 19, 2021
Coronary Stent Restenosis Trial in Szeged, Budapest (Intravascular management of prior implanted coronary drug eluting stent
Recruiting
- Coronary Stent Restenosis
- Intravascular management of prior implanted coronary drug eluting stent restenosis
-
Szeged, Csongád-Csanád, Hungary
- +1 more
Jun 27, 2022
Drug-eluting Stent, Coronary Artery Disease Trial in Yongin (Genoss DES)
Recruiting
- Drug-eluting Stent
- Coronary Artery Disease
- Genoss DES
-
Yongin, Gyeonggi-do, Korea, Republic ofYongin Severance Hospital
Jul 2, 2022
Acute Coronary Syndrome, Drug-Eluting Stents Trial in Iksan (Aspirin, Colchicine)
Recruiting
- Acute Coronary Syndrome
- Drug-Eluting Stents
-
Iksan, Korea, Republic ofWonkwang University Hospital
Jun 25, 2021
Coronary Artery Disease Trial in Nanjing (Angiography, IVUS, DES implantation)
Completed
- Coronary Artery Disease
- Angiography
- +2 more
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Nov 1, 2020
Coronary Artery Disease, Coronary Stenosis, Stent Restenosis Trial in Torino (Percutaneous coronary intervention with the
Recruiting
- Coronary Artery Disease
- +4 more
- Percutaneous coronary intervention with the following platforms: Orsiro; Mistent; BioMime; Supraflex Cruz
-
Torino, ItalyFabrizio D'Ascenzo
Jan 19, 2022